Table 3. Impact of the COVID-19 pandemic on takotsubo syndrome.
P: Pearson chi-square test; L: logistic regression; Ln: linear regression.
P-value < 0.05 indicates statistical significance.
Pre-COVID-19 pandemic (2017-2018) | COVID-19 pandemic (2020-2021) | 95% confidence interval | P-value | |
Mortality rate in takotsubo patients (%) | 6.04 | 8.67 | - | <0.001P |
Odds of mortality in takotsubo patients | ||||
-Unadjusted | 1 | 1.47 | 1.35 - 1.61 | <0.001L |
-Adjusted with COVID-19 status | 1 | 1.28 | 1.17 - 1.41 | <0.001L |
-Adjusted with multiple potential confounders and covariates | 1 | 1.28 | 1.17 - 1.41 | <0.001L |
Length of stay (LOS) of takotsubo admissions | ||||
-Mean (days) (95% CI) | 6.9 (6.7-7.1) | 7.2 (7.1-7.5) | - | - |
-Day increase in LOS | 0 | 0.43 | 0.15 - 0.70 | 0.003Ln |
-Adjusted with COVID-19 status (days) | 0 | 0.12 | -0.16 - 0.39 | 0.404Ln |
-Adjusted with multiple potential confounders covariates (days) | 0 | -0.004 | -0.24 - 0.23 | 0.975Ln |